650 related articles for article (PubMed ID: 9242611)
1. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.
Sheridan JP; Marsters SA; Pitti RM; Gurney A; Skubatch M; Baldwin D; Ramakrishnan L; Gray CL; Baker K; Wood WI; Goddard AD; Godowski P; Ashkenazi A
Science; 1997 Aug; 277(5327):818-21. PubMed ID: 9242611
[TBL] [Abstract][Full Text] [Related]
2. An antagonist decoy receptor and a death domain-containing receptor for TRAIL.
Pan G; Ni J; Wei YF; Yu G; Gentz R; Dixit VM
Science; 1997 Aug; 277(5327):815-8. PubMed ID: 9242610
[TBL] [Abstract][Full Text] [Related]
3. Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1.
Bernard D; Quatannens B; Vandenbunder B; Abbadie C
J Biol Chem; 2001 Jul; 276(29):27322-8. PubMed ID: 11350953
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
5. Control of apoptosis signaling by Apo2 ligand.
Marsters SA; Pitti RA; Sheridan JP; Ashkenazi A
Recent Prog Horm Res; 1999; 54():225-34. PubMed ID: 10548878
[TBL] [Abstract][Full Text] [Related]
6. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
7. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kim K; Fisher MJ; Xu SQ; el-Deiry WS
Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508
[TBL] [Abstract][Full Text] [Related]
9. Expression of TRAIL (Apo2L), DR4 (TRAIL receptor 1), DR5 (TRAIL receptor 2) and TRID (TRAIL receptor 3) genes in multidrug resistant human acute myeloid leukemia cell lines that overexpress MDR 1 (HL60/Tax) or MRP (HL60/AR).
Kim CH; Gupta S
Int J Oncol; 2000 Jun; 16(6):1137-9. PubMed ID: 10811986
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two receptors for TRAIL.
Schneider P; Bodmer JL; Thome M; Hofmann K; Holler N; Tschopp J
FEBS Lett; 1997 Oct; 416(3):329-34. PubMed ID: 9373179
[TBL] [Abstract][Full Text] [Related]
11. A novel receptor for Apo2L/TRAIL contains a truncated death domain.
Marsters SA; Sheridan JP; Pitti RM; Huang A; Skubatch M; Baldwin D; Yuan J; Gurney A; Goddard AD; Godowski P; Ashkenazi A
Curr Biol; 1997 Dec; 7(12):1003-6. PubMed ID: 9382840
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
[TBL] [Abstract][Full Text] [Related]
13. The receptor for the cytotoxic ligand TRAIL.
Pan G; O'Rourke K; Chinnaiyan AM; Gentz R; Ebner R; Ni J; Dixit VM
Science; 1997 Apr; 276(5309):111-3. PubMed ID: 9082980
[TBL] [Abstract][Full Text] [Related]
14. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.
Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS
Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of a set of monoclonal antibodies to TRAIL and TRAIL receptors DR4, DR5, DcR1, and DcR2.
Liu XS; Zhu Y; Han WN; Li YN; Chen LH; Jia W; Song CJ; Liu F; Yang K; Li Q; Jin BQ
Hybrid Hybridomics; 2003 Apr; 22(2):121-5. PubMed ID: 12831538
[TBL] [Abstract][Full Text] [Related]
17. Cell death: TRAIL and its receptors.
Golstein P
Curr Biol; 1997 Dec; 7(12):R750-3. PubMed ID: 9382834
[TBL] [Abstract][Full Text] [Related]
18. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
19. How TRAIL kills cancer cells, but not normal cells.
Gura T
Science; 1997 Aug; 277(5327):768. PubMed ID: 9273698
[No Abstract] [Full Text] [Related]
20. Characterization of tumour necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in the adult human testis.
Grataroli R; Vindrieux D; Selva J; Felsenheld C; Ruffion A; Decaussin M; Benahmed M
Mol Hum Reprod; 2004 Feb; 10(2):123-8. PubMed ID: 14742697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
